These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 20463417

  • 1. A review of insulin pen devices.
    McCoy EK, Wright BM.
    Postgrad Med; 2010 May; 122(3):81-8. PubMed ID: 20463417
    [Abstract] [Full Text] [Related]

  • 2. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL, Ignaut DA, Bodie JN.
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [Abstract] [Full Text] [Related]

  • 3. Insulin pens: the modern delivery devices.
    Baruah MP.
    J Assoc Physicians India; 2011 Apr; 59 Suppl():38-40. PubMed ID: 21823254
    [Abstract] [Full Text] [Related]

  • 4. Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use.
    Perfetti R.
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S79-85. PubMed ID: 20515312
    [Abstract] [Full Text] [Related]

  • 5. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T, Edelman S, Walter C, Lecointre B, Spollett G.
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K, Ory C, Vanderplas A, Nicklasson L, Lyness W, Cobden D, Chang E.
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [Abstract] [Full Text] [Related]

  • 8. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
    Goldstein HH.
    Postgrad Med; 2008 Sep; 120(3):172-9. PubMed ID: 18824835
    [Abstract] [Full Text] [Related]

  • 9. Overview of insulin delivery pen devices.
    Kroon L.
    J Am Pharm Assoc (2003); 2009 Sep; 49(5):e118-31. PubMed ID: 19692314
    [Abstract] [Full Text] [Related]

  • 10. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [Abstract] [Full Text] [Related]

  • 11. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S, Kelly WC, Garg S.
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [Abstract] [Full Text] [Related]

  • 12. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV, Shane-McWhorter L, Raparla S.
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Devices for insulin administration.
    Hill J.
    Nurs Times; 2010 Jun; 99(15):51-2. PubMed ID: 12733296
    [Abstract] [Full Text] [Related]

  • 15. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M, Bell D, Jacobsen C, Suwannasari R, FlexPen Study Team.
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [Abstract] [Full Text] [Related]

  • 16. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M, Galic E, Cabrijan T, Ivandic A, Petrusic A, Wyatt J, Mincheva N, Milicevic Z, Malone J.
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [Abstract] [Full Text] [Related]

  • 17. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg SK.
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [Abstract] [Full Text] [Related]

  • 18. Predictors of initiating rapid-acting insulin analog using vial/syringe, prefilled pen, and reusable pen devices in patients with type 2 diabetes.
    Lee LJ, Anderson J, Foster SA, Corrigan SM, Smith DM, Curkendall S.
    J Diabetes Sci Technol; 2010 May 01; 4(3):547-57. PubMed ID: 20513319
    [Abstract] [Full Text] [Related]

  • 19. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A, Spollett G.
    Expert Opin Drug Deliv; 2007 Mar 01; 4(2):165-74. PubMed ID: 17335413
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.